These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31630477)

  • 41. Epidemiology and outcomes of invasive aspergillosis among pediatric immunocompromised patients: A 12-year single-center experience.
    Al Dhaheri F; Lee RA; Sharma TS; Nakamura MM; Marty FM
    Med Mycol; 2022 Mar; 60(4):. PubMed ID: 35138378
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antifungal prophylaxis in liver transplant recipients: one size does not fit all.
    Giannella M; Bartoletti M; Morelli M; Cristini F; Tedeschi S; Campoli C; Tumietto F; Bertuzzo V; Ercolani G; Faenza S; Pinna AD; Lewis RE; Viale P
    Transpl Infect Dis; 2016 Aug; 18(4):538-44. PubMed ID: 27237076
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Invasive fungal infections in solid organ transplant recipients.
    Gavaldà J; Meije Y; Fortún J; Roilides E; Saliba F; Lortholary O; Muñoz P; Grossi P; Cuenca-Estrella M;
    Clin Microbiol Infect; 2014 Sep; 20 Suppl 7():27-48. PubMed ID: 24810152
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management.
    Singh N; Husain S
    J Heart Lung Transplant; 2003 Mar; 22(3):258-66. PubMed ID: 12633692
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of voriconazole-resistant invasive aspergillosis and its impact on mortality in haematology patients.
    Resendiz-Sharpe A; Mercier T; Lestrade PPA; van der Beek MT; von dem Borne PA; Cornelissen JJ; De Kort E; Rijnders BJA; Schauwvlieghe AFAD; Verweij PE; Maertens J; Lagrou K
    J Antimicrob Chemother; 2019 Sep; 74(9):2759-2766. PubMed ID: 31236587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Does Post-Transplant Cytomegalovirus Increase the Risk of Invasive Aspergillosis in Solid Organ Transplant Recipients? A Systematic Review and Meta-Analysis.
    Chuleerarux N; Thongkam A; Manothummetha K; Nematollahi S; Dioverti-Prono V; Torvorapanit P; Langsiri N; Worasilchai N; Plongla R; Chindamporn A; Sanguankeo A; Permpalung N
    J Fungi (Basel); 2021 Apr; 7(5):. PubMed ID: 33922773
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Posaconazole as salvage therapy in patients with invasive fungal infections after solid organ transplant.
    Alexander BD; Perfect JR; Daly JS; Restrepo A; Tobón AM; Patino H; Hardalo CJ; Graybill JR
    Transplantation; 2008 Sep; 86(6):791-6. PubMed ID: 18813103
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Invasive mold infections in iatrogenically immunocompromised children: an eight-yr review.
    Al-Rezqi A; Hawkes M; Doyle J; Richardson SE; Allen U
    Pediatr Transplant; 2009 Aug; 13(5):545-52. PubMed ID: 18992060
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The epidemiology of invasive fungal infections in transplant recipients.
    Elhaj Mahmoud D; Hérivaux A; Morio F; Briard B; Vigneau C; Desoubeaux G; Bouchara JP; Gangneux JP; Nevez G; Le Gal S; Papon N
    Biomed J; 2024 Jun; 47(3):100719. PubMed ID: 38580051
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study.
    Gavalda J; Len O; San Juan R; Aguado JM; Fortun J; Lumbreras C; Moreno A; Munoz P; Blanes M; Ramos A; Rufi G; Gurgui M; Torre-Cisneros J; Montejo M; Cuenca-Estrella M; Rodriguez-Tudela JL; Pahissa A;
    Clin Infect Dis; 2005 Jul; 41(1):52-9. PubMed ID: 15937763
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Invasive pulmonary aspergillosis in solid-organ transplant patients in the intensive care unit.
    Klein J; Rello J; Dimopoulos G; Bulpa P; Blot K; Vogelaers D; Blot S
    Transpl Infect Dis; 2022 Feb; 24(1):e13746. PubMed ID: 34843161
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patient Characteristics and Risk Factors in Invasive Mold Infections: Comparison from a Systematic Review and Database Analysis.
    Sung AH; Martin S; Phan B; Benigno M; Stephens J; Chambers R; Aram JA
    Clinicoecon Outcomes Res; 2021; 13():593-602. PubMed ID: 34211287
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Role of anidulafungin in solid organ transplant recipients].
    Aguado JM; Ayats J
    Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 14():29-34. PubMed ID: 19572432
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genomic characterization of recurrent mold infections in thoracic transplant recipients.
    Messina JA; Wolfe CR; Hemmersbach-Miller M; Milano C; Todd JL; Reynolds J; Alexander BD; Schell WA; Cuomo CA; Perfect JR
    Transpl Infect Dis; 2018 Oct; 20(5):e12935. PubMed ID: 29851203
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhaled amphotericin B for prophylaxis against invasive Aspergillus infections.
    Mohammad RA; Klein KC
    Ann Pharmacother; 2006 Dec; 40(12):2148-54. PubMed ID: 17148653
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Real-Life Considerations on Antifungal Treatment Combinations for the Management of Invasive Mold Infections after Allogeneic Cell Transplantation.
    Glampedakis E; Roth R; Masouridi-Levrat S; Chalandon Y; Mamez AC; Giannotti F; Van Delden C; Neofytos D
    J Fungi (Basel); 2021 Sep; 7(10):. PubMed ID: 34682233
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changing Epidemiology of Invasive Mold Infections in Patients Receiving Azole Prophylaxis.
    Lamoth F; Chung SJ; Damonti L; Alexander BD
    Clin Infect Dis; 2017 Jun; 64(11):1619-1621. PubMed ID: 28199491
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety of anidulafungin in solid organ transplant recipients.
    Aguado JM; Varo E; Usetti P; Pozo JC; Moreno A; Catalán M; Len O; Blanes M; Solé A; Muñoz P; Montejo M;
    Liver Transpl; 2012 Jun; 18(6):680-5. PubMed ID: 22328277
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epidemiology of invasive fungal infections after liver transplantation and the risk factors of late-onset invasive aspergillosis.
    Nagao M; Fujimoto Y; Yamamoto M; Matsumura Y; Kaido T; Takakura S; Uemoto S; Ichiyama S
    J Infect Chemother; 2016 Feb; 22(2):84-9. PubMed ID: 26683245
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Invasive Fungal Infections in Inpatient Solid Organ Transplant Recipients With COVID-19: A Multicenter Retrospective Cohort.
    Permpalung N; Chiang TP; Manothummetha K; Ostrander D; Datta K; Segev DL; Durand CM; Mostafa HH; Zhang SX; Massie AB; Marr KA; Avery RK
    Transplantation; 2024 Jul; 108(7):1613-1622. PubMed ID: 38419156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.